Patents Assigned to NEUMORA THERAPEUTICS, INC.
  • Patent number: 11942224
    Abstract: A system for evaluating mental health of patients includes a memory and a control system. The memory contains executable code storing instructions for performing a method. The control system is coupled to the memory and includes one or more processors. The control system is configured to execute the machine executable code to cause the control system to perform the method: A selection of answers associated with a patient is received. The selection of answers corresponds to each question in a series of questions from mental health questionnaires. Unprocessed MRI data are received. The unprocessed MRI data correspond to a set of MRI images of a biological structure associated with the patient. The unprocessed MRI data is processed to output a set of MRI features. Using a machine learning model, the selection of answers and the set of MRI features are processed to output a mental health indication of the patient.
    Type: Grant
    Filed: January 3, 2022
    Date of Patent: March 26, 2024
    Assignee: NEUMORA THERAPEUTICS, INC.
    Inventors: Yuelu Liu, Monika Sharma Mellem, Parvez Ahammad, Humberto Andres Gonzalez Cabezas, Matthew Kollada
  • Patent number: 11887724
    Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for generating a clinical recommendation for medical treatment of a patient.
    Type: Grant
    Filed: October 5, 2022
    Date of Patent: January 30, 2024
    Assignee: Neumora Therapeutics, Inc.
    Inventors: Tathagata Banerjee, Matthew Edward Kollada, Amirsina Torfi, Peter Crocker
  • Patent number: 11857322
    Abstract: A system includes a display device, a user interface, a memory, and a control system. The memory contains machine readable medium including machine executable code storing instructions for performing a method. The control system is coupled to the memory, and includes one or more processors. The control system is configured to execute the machine executable code to cause the control system to display, on the display device, a series of questions from mental health questionnaires. The series of questions includes text and answers for each question. From the user interface, a selection of answers of each of the displayed series of questions is received from a patient. Using a Bayesian Decision List, the received selection of answers is processed to output an indication of mental health of the patient. The indication of mental health identifies a kappa opioid receptor antagonist to which the patient would likely be a higher responder.
    Type: Grant
    Filed: July 26, 2021
    Date of Patent: January 2, 2024
    Assignee: NEUMORA THERAPEUTICS, INC.
    Inventors: Qingzhu Gao, Humberto Andres Gonzalez Cabezas, Parvez Ahammad, Yuelu Liu
  • Patent number: 11858943
    Abstract: Compounds are provided that antagonize vasopressin receptors, particularly the V1a receptor products containing such compounds, as well as to methods of their use and synthesis. Such compounds have the structure of Formula (I), or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof: wherein A, B, G, R1, R1b, R1c, R2 and X are as defined herein.
    Type: Grant
    Filed: October 13, 2021
    Date of Patent: January 2, 2024
    Assignee: NEUMORA THERAPEUTICS, INC.
    Inventors: Robert M. Jones, Mariangela Urbano, Gary Brandt, David Hardick, Chris Knight, Jason Tierney
  • Patent number: 11842793
    Abstract: The present tools and methods for detecting, diagnosing, predicting, prognosticating, or treating a neurobehavioral phenotype in a subject. These tools and methods relates to a genotype and neurophenotype topography-based approach for analyzing brain neuroimaging and gene expression maps to identify drug targets associated with neurobehavioral phenotypes and, conversely, neurobehavioral phenotypes associated with potential drug targets, to develop rational design and application of pharmacological therapeutics for brain disorders, and to provide methods and tools for treatment of subjects in need of neurological therapy.
    Type: Grant
    Filed: February 3, 2021
    Date of Patent: December 12, 2023
    Assignee: NEUMORA THERAPEUTICS, INC.
    Inventors: John D. Murray, Alan Anticevic, William J. Martin
  • Patent number: 11798681
    Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for jointly training an encoder neural network and a decoder neural network. In one aspect, a method comprises: updating current values of a set of encoder parameters and current values of a set of decoder parameters using gradients of a reconstruction loss function that measures an error in a reconstruction of multi-modal data from a training example, wherein: the reconstruction loss function comprises a plurality of scaling factors that each scale a respective term in the reconstruction loss function that measures an error in the reconstruction of a corresponding proper subset of feature dimensions of the multi-modal data from the training example.
    Type: Grant
    Filed: October 5, 2022
    Date of Patent: October 24, 2023
    Assignee: Neumora Therapeutics, Inc.
    Inventors: Tathagata Banerjee, Matthew Edward Kollada
  • Patent number: 11791016
    Abstract: The present disclosure relates to computer generated topographies from computer correlations of neurobehavioral phenotype mapping data and gene expression mapping data. Neurobehavioral phenotype mapping data is obtained for a selected phenotype and correlated with gene expression mapping data for one or more genes to define a phenotype-gene pair topography for each phenotype-gene pair. A score for each phenotype-gene pair is determined based on the correlation. The scores are used to identify genes, or drug targets, associated with the respective gene of the respective phenotype-gene pair. Conversely, gene expression mapping data is obtained for a selected gene and correlated with neurobehavioral phenotype mapping data for one or more phenotypes to define a gene-phenotype topography for each gene-phenotype pair. A score for each gene-phenotype pair is determined based on the correlation. The scores are used to identify a phenotype associated with the respective phenotype-gene pair.
    Type: Grant
    Filed: October 2, 2018
    Date of Patent: October 17, 2023
    Assignees: Neumora Therapeutics, Inc., Yale University
    Inventors: John D. Murray, Alan Anticevic, William J. Martin
  • Patent number: 11742076
    Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for generating multi-modal data archetypes. In one aspect, a method comprises obtaining a plurality of training examples, wherein each training example corresponds to a respective patient and includes multi-modal data, having a plurality of feature dimensions, that characterizes the patient; jointly training an encoder neural network and a decoder neural network on the plurality of training examples; and generating a plurality of multi-modal data archetypes that each correspond to a respective dimension of a latent space, comprising, for each multi-modal data archetype: processing a predefined embedding that represents the corresponding dimension of the latent space using the decoder neural network to generate multi-modal data, having the plurality of feature dimensions, that defines the multi-modal data archetype.
    Type: Grant
    Filed: October 5, 2022
    Date of Patent: August 29, 2023
    Assignee: Neumora Therapeutics, Inc.
    Inventors: Tathagata Banerjee, Matthew Edward Kollada
  • Patent number: 11715564
    Abstract: Systems and methods for utilizing machine learning to generate a trans-diagnostic classifier that is operative to concurrently diagnose a plurality of different mental health disorders using a single trans-diagnostic questionnaire that includes a plurality of questions (e.g., 17 questions). Machine learning techniques are used to process labeled training data to build statistical models that include trans-diagnostic item-level questions as features to create a screen to classify groups of subjects as either healthy or as possibly having a mental health disorder. A subset of questions are selected from the multiple self-administered mental health questionnaires and used to autonomously screen subjects across multiple mental health disorders without physician involvement, optionally remotely and repeatedly, in a short amount of time.
    Type: Grant
    Filed: May 1, 2019
    Date of Patent: August 1, 2023
    Assignee: NEUMORA THERAPEUTICS, INC.
    Inventors: Monika Sharma Mellem, Yuelu Liu, Parvez Ahammad, Humberto Andres Gonzalez Cabezas, William J. Martin, Pablo Christian Gersberg
  • Patent number: 11676732
    Abstract: Systems and methods for utilizing machine learning to generate a trans-diagnostic classifier that is operative to concurrently diagnose a plurality of different mental health disorders using a single trans-diagnostic questionnaire that includes a plurality of questions (e.g., 17 questions). Machine learning techniques are used to process labeled training data to build statistical models that include trans-diagnostic item-level questions as features to create a screen to classify groups of subjects as either healthy or as possibly having a mental health disorder. A subset of questions is selected from the multiple self-administered mental health questionnaires and used to autonomously screen subjects across multiple mental health disorders without physician involvement, optionally remotely and repeatedly, in a short amount of time.
    Type: Grant
    Filed: September 1, 2021
    Date of Patent: June 13, 2023
    Assignee: NEUMORA THERAPEUTICS, INC.
    Inventors: Monika Sharma Mellem, Yuelu Liu, Parvez Ahammad, Humberto Andres Gonzalez Cabezas, William J. Martin, Pablo Christian Gersberg
  • Patent number: 11670417
    Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for classifying a patient. In one aspect, a method comprises: receiving multi-modal data characterizing a patient, wherein the multi-modal data comprises a respective feature representation for each of a plurality of modalities; processing the multi-modal data characterizing the patient using an encoder neural network to generate an embedding of the multi-modal data characterizing the patient; determining a respective classification score for each patient category in a set of patient categories based on the embedding of the multi-modal data characterizing the patient; and classifying the patient as being included in a corresponding patient category from the set of patient categories based on the classification scores.
    Type: Grant
    Filed: October 5, 2022
    Date of Patent: June 6, 2023
    Assignee: Neumora Therapeutics, Inc.
    Inventors: Tathagata Banerjee, Matthew Edward Kollada
  • Publication number: 20220392637
    Abstract: Methods and systems are provided for diagnosing mental health conditions using multiple data modalities. In particular, a trained machine learning model is used for mental health diagnosis, wherein the trained model utilizes a dynamic fusion approach for capturing and preserving interactions as well as timing information between the multiple data modalities.
    Type: Application
    Filed: May 10, 2022
    Publication date: December 8, 2022
    Applicant: NEUMORA THERAPEUTICS, INC.
    Inventors: Matthew Kollada, Tathagata Banerjee